June 29, 2020 / 12:04 PM / 13 days ago

BRIEF-Cytocom Reports Successful Completion of FDA Meeting Regarding Trial Of CYTO-201 In COVID-19

June 29 (Reuters) -

* CYTOCOM, INC. ANNOUNCES SUCCESSFUL COMPLETION OF TYPE-B PRE-IND MEETING WITH FDA REGARDING PROPOSED PHASE 2 CLINICAL TRIAL OF CYTO-201 IN COVID-19 PATIENTS Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below